For the quarter ending 2026-03-31, AGL made $1,420,460K in revenue. $48,916K in net income. Net profit margin of 3.44%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 1,420,460 | 1,569,491 | 1,435,321 | 1,394,982 |
| Expenses-Medical Services | 1,269,628 | 1,596,012* | 1,489,479 | 1,445,245 |
| Expenses-Other Operating | 85,817 | 91,213* | 13,488 | 2,164 |
| General and administrative | 54,231 | 60,101 | 56,198 | 56,281 |
| Depreciation and amortization | 6,787 | 6,969 | 7,430 | 7,319 |
| Impairments | - | 9,021* | - | - |
| Total expenses | 1,416,463 | 1,763,316 | 1,566,595 | 1,511,009 |
| Income (loss) from operations | 3,997 | -193,825 | -131,274 | -116,027 |
| Income (loss) from equity method investments | 11,733 | -33,052 | 13,133 | 5,412 |
| Other income (expense), net | 16,025 | 41,035 | 9,441 | 7,879 |
| Interest expense | 1,811 | 1,716 | 1,838 | 1,572 |
| Income (loss) before income taxes | 29,944 | -187,558 | -110,538 | -104,308 |
| Income tax benefit (expense) | 28 | 1,324 | -331 | 62 |
| Income (loss) from continuing operations | 29,916 | -188,882 | -110,207 | -104,370 |
| Income (loss) before gain (loss) on sales | - | 0 | 0 | 0 |
| Adjustments on sale of assets, net | 19,000 | 0 | 0 | 0 |
| Total discontinued operations | - | 0 | 0 | 0 |
| Net income (loss) | - | -188,882 | -110,207 | -104,370 |
| Noncontrolling interests share in (earnings) loss | - | 0 | 0 | 0 |
| Net income (loss) attributable to common shares | 48,916 | -188,882 | -110,207 | -104,370 |
| Basic EPS | 2.95 | - | - | - |
| Diluted EPS | 2.94 | - | - | - |
| Basic Average Shares | 16,599,000 | 414,639,000 | 414,465,000 | 413,836,000 |
| Diluted Average Shares | 16,662,000 | 414,639,000 | 414,465,000 | 413,836,000 |
agilon health, inc. (AGL)
agilon health, inc. (AGL)